AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Dec 2, 2025
30071_dirs_2025-12-02_95bf7a3d-8139-4410-b146-642f76c25ee0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-12-01
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-01 | ResMed Common Stock | S | 1000 | $244.16 | Disposed | 87495 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29